UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051729
Receipt number R000057014
Scientific Title Research on the construction of a remote consultation system for young children with suspected autism spectrum disorder and their parents
Date of disclosure of the study information 2023/07/27
Last modified on 2023/07/28 09:43:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the construction of a remote consultation system for young children with suspected autism spectrum disorder and their parents

Acronym

Research on the construction of a remote consultation system for young children with suspected ASD and their parents

Scientific Title

Research on the construction of a remote consultation system for young children with suspected autism spectrum disorder and their parents

Scientific Title:Acronym

Research on the construction of a remote consultation system for young children with suspected ASD and their parents

Region

Japan


Condition

Condition

Autism Spectrum Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the effect of providing developmental counseling to ASD patients and their families using an existing remote counseling system to improve the quality of life of parents in raising ASD children, and to study the feasibility of implementing this service.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change from baseline to 3 months in total Parenting Stress Index Short Form (PSI-SF) score for intervention and control groups

Key secondary outcomes

Change from baseline to 3 months in WHO-5 total score (intervention and control groups)
Change from baseline to 3 months in the PSI-SF Child Aspects (intervention and control groups)
Change from baseline to 3 months for the parental dimension of the PSI-SF (intervention and control groups)
Change in PSI-SF total score at 3 and 6 months (intervention and control groups)
Change in WHO-5 total score at 3 and 6 months (intervention and control groups)
Change in PSI-SF Child Aspects at 3 and 6 months (intervention and control groups)
Change in PSI-SF Parent Aspects at 3 and 6 months (intervention and control groups)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

After consent is confirmed, the intervention group will be sent the URL for downloading the Online Medical Pocket Doctor to their own smartphones before the intervention is conducted. The intervention group will continue to use the developmental consultation service, which will be provided 21 times a month for about 30 minutes per session for a period of 3 months, using the application dedicated to the Online Medical Consultation Pocket Doctor. The "developmental consultation" in this study is a response to developmental consultations from parents by a physician with knowledge of child psychiatry, a psychologist, or a rehabilitation specialist, who is a co-researcher, and does not provide medical treatment, diagnosis, or developmental testing.
The specific content of the online consultation is as follows
First session: Listening to and evaluating what the parents have to say (results of assessment sheets and questionnaires)
Second session: Gather information on the development of the child of concern (current situation of the parents/caregivers and parents/children, understanding of the child's development) and find out what the parents are having trouble with and what they perceive as problems in their child's development.
Session 3: To understand children's development and characteristics by asking parents how they respond to their children's behavior and how their children react to it, and to think about how to respond and cope with it together with the parents.
Session 4: Summary, the need for parent-child relationships and connections with medical institutions and rehabilitation institutions, and the future (results of the questionnaire)

Interventions/Control_2

The control group receives only general community support for children with ASD or suspected ASD.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Parents with preschool children who are members of the Society for Physical Activity and Rehabilitation of Children in Japan (SPARK Association) and who have confirmed that they meet the criteria for ASD
For children who have not been diagnosed with ASD at a medical institution, a physician qualified as a psychiatrist by the Japanese Neuropsychiatric Association or a pediatrician by the Japanese Pediatric Society at the time of consent is obtained, and a psychiatrist or pediatrician qualified as a specialist in the diagnosis criteria of the American Psychiatric Association, Diagnostic Determine if the criteria for ASD can be confirmed to be met based on the Diagnostic Statistical Manual-5 (DSM-5), the diagnostic criteria of the American Psychiatric Association
2. agree with the content of the study and give their consent to participate in the study
3. have access to the Online Medical Pocket Doctor via Internet connection throughout the study period or agree to participate in the study using the Online Medical Pocket Doctor on a smartphone that will be loaned to them
4. who can download and use the dedicated application for Online Doctor Pocket Doctor on their own smartphone
5. who can understand the Japanese language described in the consent document and questionnaire

Key exclusion criteria

1. those who require a surrogate
2. who are undergoing treatment for psychiatric disorders and for whom psychiatric treatment should be prioritized over consultation for this study
3. who are otherwise deemed inappropriate to participate in this study by the Principal Investigator or the Principal Investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yoshiyuki
Middle name
Last name Tachibana

Organization

National Center for Child Health and Development

Division name

Hospital

Zip code

157-8535

Address

2-10-1 Okura Setagaya-ku Tokyo

TEL

03-5494-7120

Email

tachibana-y@ncchd.go.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Tachibana

Organization

National Center for Child Health and Development

Division name

Hospital

Zip code

157-8535

Address

2-10-1 Okura Setagaya-ku Tokyo

TEL

03-5494-7120

Homepage URL


Email

tachibana-y@ncchd.go.jp


Sponsor or person

Institute

National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Child Health and Development Ethics Review Committee Secretariat

Address

2-10-1 Okura Setagaya-ku Tokyo

Tel

03-5494-7243

Email

rinri@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 07 Month 12 Day

Date of IRB

2023 Year 07 Month 12 Day

Anticipated trial start date

2023 Year 07 Month 27 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 07 Month 27 Day

Last modified on

2023 Year 07 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057014


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name